ALIVE Israel Healthtech Fund

ALIVE Israel Healthtech Fund Overview

ALIVE Israel Healthtech Fund is a mid-to-late-stage healthtech investment fund that operates through a strategic partnership model to support the clinical and commercial expansion of its portfolio companies. The fund focuses on Medtech, Digital Health, and Bio Convergence, with a strong emphasis on the U.S. market and global outreach. By collaborating with hospital chains, HMOs, financial institutions, venture capital firms, and crossover funds, the fund facilitates regulatory progress, business plan execution, and strategic growth for its portfolio companies.

Latest News

Mar 25, 2025 · en.globes.co.il

growth-positive

Navina equips clinicians and care teams with real-time, data-driven insights that improve the quality of care and financial outcomes.

Navina, an Israeli AI-powered clinical intelligence company, has completed a $55 million Series C financing round led by Growth Equity at Goldman Sachs Alternatives, with participation from existing investors. The funds will be used to expand in the US healthcare market, further develop AI technology, and improve patient outcomes. Navinas platform, which serves over 10,000 healthcare professionals across 1,300 clinics, has secured partnerships with industry leaders like agilon health and InnovaCare Health. The company is recognized for its high customer satisfaction and trust, and its AI copilot is a trusted solution for value-based care organizations.

InvestmentPartnersCustomers

Jul 23, 2024 · www.prnewswire.com

growth-positive

Magenta Medical Closes $105M Financing Led by Novo Holdings

Magenta Medical, a developer of the Elevate™ heart pump, has secured $105 million in a financing round led by Novo Holdings, with participation from new investors Viking Global Investors and RA Capital Management, as well as existing investors. The funding will support Magentas U.S. clinical programs and efforts to secure FDA approval for the Elevate™ System, designed for high-risk percutaneous coronary interventions. The Elevate™ pump, noted for its small size and minimally invasive placement, has been granted Breakthrough Device Designation by the FDA. Magenta aims to disrupt the mechanical circulatory support market with its innovative technology.

InvestmentProduct Stage

Jul 16, 2024 · www.calcalistech.com

growth-positive

Innovalve acquired for $300 million in cash by medical device giant Edwards Lifesciences | CTech

Innovalve Bio Medical, an Israeli startup specializing in artificial mitral valve technology, is being acquired by Edwards Lifesciences for approximately $300 million. Innovalves technology, which allows for minimally invasive heart valve replacement, has received FDA approval for clinical studies and has been successfully used in over 40 surgeries. The acquisition is expected to be completed by the end of 2024. Innovalve has raised around $30 million from investors including ALIVE VC, OurCrowd, and CBG Group. The acquisition marks a significant exit for the ALIVE fund, highlighting the growing impact of Israeli innovation in the medical technology sector.

Acquired-byFDA approved/pending approval

Aug 12, 2021 · www.calcalist.co.il

growth-positive

מנורה מבטחים מצטרפת להשקעה בקרן הבריאות ALIVE כלכליסט

מנורה מבטחים הצטרפה להשקעה בקרן ALIVE, קרן ה-HealthTech שייסד פרופ ארי שמיס. הקרן הוקמה על ידי פרופ ארי שמיס ומיועדת לעמוד על 150 מיליון דולר. מנורה מבטחים תשקיע כ-20 מיליון דולר בקרן. בנוסף למנורה מבטחים, ישנם משקיעים נוספים בקרן, כולל לאומי פרטנרס, קרן מכבי, CBG, Carilion Clinic, אחזקות מאיחוד האמירויות ומשקיעים פרטיים.

Investment

Apr 28, 2021 · m-jpost-com.cdn.ampproject.org

growth-positive

ALIVE and thriving: Pushing the boundaries of health technology

ALIVE, a $150 million health-tech fund, is investing in medical devices and digital health. The fund focuses on mid- to late-stage health technology and works with companies that have a mature vision. ALIVE collaborates with Assuta chain of hospitals, the Maccabi health system, and Carilion Clinic in the United States. The fund has invested in companies like Medisafe, Innovalve Bio Medical, and Magenta Medical. ALIVE is evaluating additional companies for possible investments. The fund is global, with investors from Israel, the United States, and other countries. ALIVE is looking forward to making more face-to-face contacts among investors and developers as the world recovers from COVID-19.

InvestmentPartners

Team Members

7

Web & Social Links

Locations

HaShikma St 1, Savyon, 5691501, Israel

Photos & Videos

1 item(s)

ALIVE Israel Healthtech Fund Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info